| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glycerol channel activity | 9.05e-06 | 7 | 129 | 3 | GO:0015254 | |
| GeneOntologyMolecularFunction | urea transmembrane transporter activity | 2.15e-05 | 9 | 129 | 3 | GO:0015204 | |
| GeneOntologyMolecularFunction | glycerol transmembrane transporter activity | 2.15e-05 | 9 | 129 | 3 | GO:0015168 | |
| GeneOntologyMolecularFunction | polyol transmembrane transporter activity | 7.19e-05 | 13 | 129 | 3 | GO:0015166 | |
| GeneOntologyMolecularFunction | water channel activity | 1.68e-04 | 17 | 129 | 3 | GO:0015250 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 1.69e-04 | 43 | 129 | 4 | GO:0008307 | |
| GeneOntologyMolecularFunction | water transmembrane transporter activity | 2.77e-04 | 20 | 129 | 3 | GO:0005372 | |
| GeneOntologyMolecularFunction | L-lactate dehydrogenase activity | 4.09e-04 | 5 | 129 | 2 | GO:0004459 | |
| GeneOntologyMolecularFunction | urea channel activity | 4.09e-04 | 5 | 129 | 2 | GO:0015265 | |
| GeneOntologyMolecularFunction | kinase activity | CDC42BPG PNKP GRK7 RPS6KA1 OBSCN STK31 PTK6 MET MTOR EPHA2 EIF2AK4 NME1 MAP2K5 ALK | 4.27e-04 | 764 | 129 | 14 | GO:0016301 |
| GeneOntologyMolecularFunction | protein kinase activity | CDC42BPG GRK7 RPS6KA1 OBSCN STK31 PTK6 MET MTOR EPHA2 EIF2AK4 MAP2K5 ALK | 5.20e-04 | 600 | 129 | 12 | GO:0004672 |
| GeneOntologyMolecularFunction | lactate dehydrogenase activity | 6.11e-04 | 6 | 129 | 2 | GO:0004457 | |
| GeneOntologyMolecularFunction | vitamin binding | 6.29e-04 | 161 | 129 | 6 | GO:0019842 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | CDC42BPG PNKP GRK7 RPS6KA1 OBSCN STK31 PTK6 MET MTOR EPHA2 EIF2AK4 MAP2K5 ALK | 6.86e-04 | 709 | 129 | 13 | GO:0016773 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | CDC42BPG PNKP GRK7 RPS6KA1 OBSCN STK31 PTK6 MET PARP1 MTOR EPHA2 EIF2AK4 NME1 MAP2K5 ALK | 1.08e-03 | 938 | 129 | 15 | GO:0016772 |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 1.10e-03 | 70 | 129 | 4 | GO:1901618 | |
| GeneOntologyBiologicalProcess | actomyosin structure organization | 2.48e-06 | 239 | 128 | 10 | GO:0031032 | |
| GeneOntologyBiologicalProcess | organophosphate metabolic process | PITPNM2 AMPD1 SLC25A42 ACACA SHMT1 LCAT LDHA SELENON LDHC AFMID PARP1 MTOR EPHA2 DLD SERAC1 PNPLA7 NME1 ENO2 TNXB ALPI PLCE1 | 7.17e-06 | 1142 | 128 | 21 | GO:0019637 |
| GeneOntologyBiologicalProcess | organic acid catabolic process | 7.80e-06 | 272 | 128 | 10 | GO:0016054 | |
| GeneOntologyBiologicalProcess | carboxylic acid catabolic process | 7.80e-06 | 272 | 128 | 10 | GO:0046395 | |
| GeneOntologyBiologicalProcess | regulation of cytoplasmic translational initiation | 1.28e-05 | 8 | 128 | 3 | GO:1904688 | |
| GeneOntologyBiologicalProcess | purine-containing compound metabolic process | AMPD1 SLC25A42 ACACA SHMT1 LDHA SELENON LDHC AFMID PARP1 MTOR EPHA2 DLD NME1 ENO2 ALPI | 1.30e-05 | 652 | 128 | 15 | GO:0072521 |
| GeneOntologyBiologicalProcess | purine ribonucleotide metabolic process | AMPD1 SLC25A42 ACACA LDHA SELENON LDHC PARP1 MTOR EPHA2 DLD NME1 ENO2 ALPI | 1.84e-05 | 512 | 128 | 13 | GO:0009150 |
| GeneOntologyBiologicalProcess | glycerol transmembrane transport | 1.91e-05 | 9 | 128 | 3 | GO:0015793 | |
| GeneOntologyBiologicalProcess | nucleotide metabolic process | AMPD1 SLC25A42 ACACA SHMT1 LDHA SELENON LDHC AFMID PARP1 MTOR EPHA2 DLD NME1 ENO2 ALPI | 2.28e-05 | 684 | 128 | 15 | GO:0009117 |
| GeneOntologyBiologicalProcess | nucleoside phosphate metabolic process | AMPD1 SLC25A42 ACACA SHMT1 LDHA SELENON LDHC AFMID PARP1 MTOR EPHA2 DLD NME1 ENO2 ALPI | 2.56e-05 | 691 | 128 | 15 | GO:0006753 |
| GeneOntologyBiologicalProcess | ribonucleotide metabolic process | AMPD1 SLC25A42 ACACA LDHA SELENON LDHC PARP1 MTOR EPHA2 DLD NME1 ENO2 ALPI | 2.79e-05 | 533 | 128 | 13 | GO:0009259 |
| GeneOntologyBiologicalProcess | purine nucleotide metabolic process | AMPD1 SLC25A42 ACACA LDHA SELENON LDHC AFMID PARP1 MTOR EPHA2 DLD NME1 ENO2 ALPI | 3.11e-05 | 619 | 128 | 14 | GO:0006163 |
| GeneOntologyBiologicalProcess | ribose phosphate metabolic process | AMPD1 SLC25A42 ACACA LDHA SELENON LDHC PARP1 MTOR EPHA2 DLD NME1 ENO2 ALPI | 3.20e-05 | 540 | 128 | 13 | GO:0019693 |
| GeneOntologyBiologicalProcess | sarcomere organization | 3.26e-05 | 59 | 128 | 5 | GO:0045214 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid catabolic process | 3.41e-05 | 145 | 128 | 7 | GO:0072329 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 3.57e-05 | 146 | 128 | 7 | GO:0051209 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 3.73e-05 | 147 | 128 | 7 | GO:0051283 | |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 4.06e-05 | 149 | 128 | 7 | GO:0051282 | |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 4.81e-05 | 153 | 128 | 7 | GO:0051208 | |
| GeneOntologyBiologicalProcess | polyol transmembrane transport | 4.93e-05 | 12 | 128 | 3 | GO:0015791 | |
| GeneOntologyBiologicalProcess | urea transmembrane transport | 4.93e-05 | 12 | 128 | 3 | GO:0071918 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 6.40e-05 | 217 | 128 | 8 | GO:0097553 | |
| GeneOntologyBiologicalProcess | small molecule catabolic process | 6.45e-05 | 421 | 128 | 11 | GO:0044282 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | SLC25A42 PLOD3 ACACA ACAT2 SHMT1 LDHA SELENON LDHC IVD AFMID ALDH1A2 MTOR AGXT DLD ADI1 ENO2 TNXB ACOXL | 7.16e-05 | 1035 | 128 | 18 | GO:0019752 |
| GeneOntologyBiologicalProcess | purine-containing compound biosynthetic process | 7.96e-05 | 288 | 128 | 9 | GO:0072522 | |
| GeneOntologyBiologicalProcess | urea transport | 8.08e-05 | 14 | 128 | 3 | GO:0015840 | |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule metabolic process | AMPD1 SLC25A42 ACACA SHMT1 LDHA SELENON LDHC AFMID PARP1 MTOR EPHA2 DLD NME1 ENO2 ALPI | 8.37e-05 | 767 | 128 | 15 | GO:0055086 |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | SLC25A42 PLOD3 ACACA ACAT2 SHMT1 LDHA SELENON LDHC IVD AFMID ALDH1A2 MTOR AGXT DLD ADI1 ENO2 TNXB ACOXL | 9.46e-05 | 1058 | 128 | 18 | GO:0043436 |
| GeneOntologyBiologicalProcess | organic acid metabolic process | SLC25A42 PLOD3 ACACA ACAT2 SHMT1 LDHA SELENON LDHC IVD AFMID ALDH1A2 MTOR AGXT DLD ADI1 ENO2 TNXB ACOXL | 1.02e-04 | 1064 | 128 | 18 | GO:0006082 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | ESPN CDC42BPG DSTN MYOM1 CAPN3 OBSCN CASP5 BBS4 NEB MET LLGL2 MTOR AKAP13 TNXB EPB41L1 | 1.39e-04 | 803 | 128 | 15 | GO:0030036 |
| GeneOntologyBiologicalProcess | nucleotide biosynthetic process | 1.72e-04 | 319 | 128 | 9 | GO:0009165 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate biosynthetic process | 1.76e-04 | 320 | 128 | 9 | GO:1901293 | |
| GeneOntologyBiologicalProcess | cytoplasm organization | 1.78e-04 | 18 | 128 | 3 | GO:0007028 | |
| GeneOntologyBiologicalProcess | myofibril assembly | 1.98e-04 | 86 | 128 | 5 | GO:0030239 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative metabolic process | AMPD1 SLC25A42 PLOD3 ACACA RPN2 SHMT1 LDHA SELENON LDHC CEMIP XYLT1 PARP1 MTOR EPHA2 UGCG DLD NME1 ENO2 ALPI | 2.00e-04 | 1226 | 128 | 19 | GO:1901135 |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 2.17e-04 | 259 | 128 | 8 | GO:0051651 | |
| GeneOntologyBiologicalProcess | muscle cell development | 2.17e-04 | 259 | 128 | 8 | GO:0055001 | |
| GeneOntologyBiologicalProcess | pyruvate catabolic process | 2.27e-04 | 4 | 128 | 2 | GO:0042867 | |
| GeneOntologyBiologicalProcess | lactate biosynthetic process from pyruvate | 2.27e-04 | 4 | 128 | 2 | GO:0019244 | |
| GeneOntologyBiologicalProcess | striated muscle cell development | 2.33e-04 | 89 | 128 | 5 | GO:0055002 | |
| GeneOntologyBiologicalProcess | pyruvate metabolic process | 2.61e-04 | 142 | 128 | 6 | GO:0006090 | |
| GeneOntologyBiologicalProcess | purine nucleotide biosynthetic process | 3.66e-04 | 280 | 128 | 8 | GO:0006164 | |
| GeneOntologyBiologicalProcess | positive regulation of cytoplasmic translational initiation | 3.77e-04 | 5 | 128 | 2 | GO:1904690 | |
| GeneOntologyBiologicalProcess | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling | 3.77e-04 | 5 | 128 | 2 | GO:0060665 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1B ABCC3 KCNH7 SLC6A17 CAPN3 SELENON TRDN ITPR2 CEMIP IBTK CLCN6 CLCN7 MTOR AHNAK SLC12A7 KCNT1 PLCE1 | 5.37e-04 | 1115 | 128 | 17 | GO:0034220 |
| GeneOntologyBiologicalProcess | actin filament-based process | ESPN CDC42BPG DSTN MYOM1 CAPN3 OBSCN CASP5 BBS4 NEB MET LLGL2 MTOR AKAP13 TNXB EPB41L1 | 5.38e-04 | 912 | 128 | 15 | GO:0030029 |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 5.61e-04 | 228 | 128 | 7 | GO:0046777 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA1B KCNH7 SLC6A17 CAPN3 SELENON TRDN ITPR2 CEMIP IBTK CLCN6 CLCN7 MTOR AHNAK SLC12A7 KCNT1 PLCE1 | 5.65e-04 | 1017 | 128 | 16 | GO:0098660 |
| GeneOntologyBiologicalProcess | purine ribonucleotide biosynthetic process | 6.21e-04 | 232 | 128 | 7 | GO:0009152 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | SLC25A42 ACACA ACAT2 LDHA LDHC IVD ALDH1A2 MTOR AGXT DLD ENO2 TNXB ACOXL | 6.27e-04 | 731 | 128 | 13 | GO:0032787 |
| GeneOntologyBiologicalProcess | carbohydrate derivative biosynthetic process | AMPD1 SLC25A42 PLOD3 ACACA RPN2 SHMT1 LDHC CEMIP XYLT1 PARP1 UGCG DLD NME1 | 6.68e-04 | 736 | 128 | 13 | GO:1901137 |
| GeneOntologyBiologicalProcess | organophosphate biosynthetic process | PITPNM2 AMPD1 SLC25A42 ACACA SHMT1 LCAT LDHC AFMID PARP1 DLD SERAC1 NME1 | 6.80e-04 | 644 | 128 | 12 | GO:0090407 |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 7.58e-04 | 29 | 128 | 3 | GO:0045948 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 7.71e-04 | 392 | 128 | 9 | GO:0070588 | |
| GeneOntologyBiologicalProcess | P granule organization | 7.86e-04 | 7 | 128 | 2 | GO:0030719 | |
| GeneOntologyBiologicalProcess | dTMP biosynthetic process | 7.86e-04 | 7 | 128 | 2 | GO:0006231 | |
| GeneOntologyBiologicalProcess | maternal determination of anterior/posterior axis, embryo | 7.86e-04 | 7 | 128 | 2 | GO:0008358 | |
| GeneOntologyBiologicalProcess | pole plasm assembly | 7.86e-04 | 7 | 128 | 2 | GO:0007315 | |
| GeneOntologyBiologicalProcess | oocyte anterior/posterior axis specification | 7.86e-04 | 7 | 128 | 2 | GO:0007314 | |
| GeneOntologyBiologicalProcess | lactate biosynthetic process | 7.86e-04 | 7 | 128 | 2 | GO:0019249 | |
| GeneOntologyBiologicalProcess | pyrimidine deoxyribonucleoside monophosphate biosynthetic process | 7.86e-04 | 7 | 128 | 2 | GO:0009177 | |
| GeneOntologyBiologicalProcess | amino acid catabolic process | 8.19e-04 | 117 | 128 | 5 | GO:0009063 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | ESPN PLOD3 DSTN MYOM1 CAPN3 OBSCN CASP5 BBS4 NEB SELENON TRDN MET MTOR AKAP13 TNXB | 8.80e-04 | 957 | 128 | 15 | GO:0097435 |
| GeneOntologyBiologicalProcess | proteinogenic amino acid biosynthetic process | 8.96e-04 | 69 | 128 | 4 | GO:0170038 | |
| GeneOntologyBiologicalProcess | ribonucleotide biosynthetic process | 8.98e-04 | 247 | 128 | 7 | GO:0009260 | |
| GeneOntologyBiologicalProcess | L-amino acid biosynthetic process | 9.45e-04 | 70 | 128 | 4 | GO:0170034 | |
| GeneOntologyBiologicalProcess | water transport | 1.02e-03 | 32 | 128 | 3 | GO:0006833 | |
| GeneOntologyBiologicalProcess | ribose phosphate biosynthetic process | 1.03e-03 | 253 | 128 | 7 | GO:0046390 | |
| GeneOntologyBiologicalProcess | one-carbon compound transport | 1.11e-03 | 33 | 128 | 3 | GO:0019755 | |
| GeneOntologyBiologicalProcess | regulatory ncRNA processing | 1.16e-03 | 74 | 128 | 4 | GO:0070918 | |
| HumanPheno | Rhabdomyolysis | 5.06e-06 | 45 | 52 | 6 | HP:0003201 | |
| Domain | - | 1.35e-04 | 3 | 126 | 2 | 4.10.1130.10 | |
| Domain | Protein_kinase_ATP_BS | CDC42BPG GRK7 RPS6KA1 OBSCN PTK6 MET EPHA2 EIF2AK4 MAP2K5 ALK | 2.51e-04 | 379 | 126 | 10 | IPR017441 |
| Domain | PROTEIN_KINASE_ATP | CDC42BPG GRK7 RPS6KA1 OBSCN STK31 PTK6 MET EPHA2 EIF2AK4 MAP2K5 ALK | 2.81e-04 | 459 | 126 | 11 | PS00107 |
| Domain | Kinase-like_dom | CDC42BPG GRK7 RPS6KA1 OBSCN STK31 PTK6 MET MTOR EPHA2 EIF2AK4 MAP2K5 ALK | 3.06e-04 | 542 | 126 | 12 | IPR011009 |
| Domain | L_LDH | 4.46e-04 | 5 | 126 | 2 | PS00064 | |
| Domain | L-lactate_DH | 4.46e-04 | 5 | 126 | 2 | IPR011304 | |
| Domain | L-lactate_DH_AS | 4.46e-04 | 5 | 126 | 2 | IPR018177 | |
| Domain | Prot_kinase_dom | CDC42BPG GRK7 RPS6KA1 OBSCN STK31 PTK6 MET EPHA2 EIF2AK4 MAP2K5 ALK | 4.80e-04 | 489 | 126 | 11 | IPR000719 |
| Domain | PROTEIN_KINASE_TYR | 5.07e-04 | 97 | 126 | 5 | PS00109 | |
| Domain | Tyr_kinase_AS | 5.07e-04 | 97 | 126 | 5 | IPR008266 | |
| Domain | PROTEIN_KINASE_DOM | CDC42BPG GRK7 RPS6KA1 OBSCN STK31 PTK6 MET EPHA2 EIF2AK4 MAP2K5 ALK | 5.14e-04 | 493 | 126 | 11 | PS50011 |
| Domain | Clathrin_mu_CS | 6.65e-04 | 6 | 126 | 2 | IPR018240 | |
| Domain | CLAT_ADAPTOR_M_1 | 6.65e-04 | 6 | 126 | 2 | PS00990 | |
| Domain | CLAT_ADAPTOR_M_2 | 6.65e-04 | 6 | 126 | 2 | PS00991 | |
| Domain | Lactate/malate_DH_N | 1.23e-03 | 8 | 126 | 2 | IPR001236 | |
| Domain | L-lactate/malate_DH | 1.23e-03 | 8 | 126 | 2 | IPR001557 | |
| Domain | Ldh_1_N | 1.23e-03 | 8 | 126 | 2 | PF00056 | |
| Domain | BTK | 1.58e-03 | 9 | 126 | 2 | SM00107 | |
| Domain | - | 1.58e-03 | 9 | 126 | 2 | 3.90.110.10 | |
| Domain | Lactate/malate_DH_C | 1.58e-03 | 9 | 126 | 2 | IPR022383 | |
| Domain | Cl-channel_core | 1.58e-03 | 9 | 126 | 2 | IPR014743 | |
| Domain | Ldh_1_C | 1.58e-03 | 9 | 126 | 2 | PF02866 | |
| Domain | - | 1.58e-03 | 9 | 126 | 2 | 1.10.3080.10 | |
| Domain | Voltage_CLC | 1.58e-03 | 9 | 126 | 2 | PF00654 | |
| Domain | Cl-channel_volt-gated | 1.58e-03 | 9 | 126 | 2 | IPR001807 | |
| Domain | Lactate_DH/Glyco_Ohase_4_C | 1.58e-03 | 9 | 126 | 2 | IPR015955 | |
| Domain | Znf_Btk_motif | 1.58e-03 | 9 | 126 | 2 | IPR001562 | |
| Domain | BTK | 1.58e-03 | 9 | 126 | 2 | PF00779 | |
| Domain | ZF_BTK | 1.58e-03 | 9 | 126 | 2 | PS51113 | |
| Domain | C2 | 1.95e-03 | 131 | 126 | 5 | PF00168 | |
| Domain | Clathrin_mu | 1.96e-03 | 10 | 126 | 2 | IPR001392 | |
| Domain | C2 | 2.37e-03 | 137 | 126 | 5 | SM00239 | |
| Domain | Adap_comp_sub | 2.39e-03 | 11 | 126 | 2 | PF00928 | |
| Domain | C2 | 2.77e-03 | 142 | 126 | 5 | PS50004 | |
| Domain | Tyr_kinase_cat_dom | 2.98e-03 | 88 | 126 | 4 | IPR020635 | |
| Domain | TyrKc | 2.98e-03 | 88 | 126 | 4 | SM00219 | |
| Domain | - | 3.31e-03 | 148 | 126 | 5 | 2.60.40.150 | |
| Domain | MHD | 3.35e-03 | 13 | 126 | 2 | PS51072 | |
| Domain | Acyl-CoA_dh_1 | 3.35e-03 | 13 | 126 | 2 | PF00441 | |
| Domain | MHD | 3.35e-03 | 13 | 126 | 2 | IPR028565 | |
| Domain | RasGAP | 3.90e-03 | 14 | 126 | 2 | SM00323 | |
| Domain | TUDOR | 3.90e-03 | 14 | 126 | 2 | PF00567 | |
| Domain | RasGAP_CS | 3.90e-03 | 14 | 126 | 2 | IPR023152 | |
| Domain | - | 4.16e-03 | 48 | 126 | 3 | 2.60.120.10 | |
| Domain | RasGAP | 4.48e-03 | 15 | 126 | 2 | PF00616 | |
| Domain | Acyl-CoA_Oxase/DH_cen-dom | 4.48e-03 | 15 | 126 | 2 | IPR006091 | |
| Domain | AcylCoA_DH/oxidase_NM_dom | 4.48e-03 | 15 | 126 | 2 | IPR009100 | |
| Domain | RAS_GTPASE_ACTIV_1 | 4.48e-03 | 15 | 126 | 2 | PS00509 | |
| Domain | Acyl-CoA_dh_M | 4.48e-03 | 15 | 126 | 2 | PF02770 | |
| Domain | RAS_GTPASE_ACTIV_2 | 4.48e-03 | 15 | 126 | 2 | PS50018 | |
| Domain | RmlC-like_jellyroll | 4.93e-03 | 51 | 126 | 3 | IPR014710 | |
| Domain | - | 5.06e-03 | 391 | 126 | 8 | 2.30.29.30 | |
| Domain | CBS | 5.09e-03 | 16 | 126 | 2 | SM00116 | |
| Domain | AP_mu_sigma_su | 5.09e-03 | 16 | 126 | 2 | IPR022775 | |
| Domain | P4Hc | 5.09e-03 | 16 | 126 | 2 | SM00702 | |
| Domain | Clat_adaptor_s | 5.09e-03 | 16 | 126 | 2 | PF01217 | |
| Domain | - | 5.09e-03 | 16 | 126 | 2 | 1.10.506.10 | |
| Domain | Disintegrin_CS | 5.09e-03 | 16 | 126 | 2 | IPR018358 | |
| Domain | Pro_4_hyd_alph | 5.09e-03 | 16 | 126 | 2 | IPR006620 | |
| Domain | AcylCo_DH/oxidase_C | 5.09e-03 | 16 | 126 | 2 | IPR009075 | |
| Domain | C2_dom | 5.11e-03 | 164 | 126 | 5 | IPR000008 | |
| Domain | AGC-kinase_C | 6.41e-03 | 56 | 126 | 3 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 6.41e-03 | 56 | 126 | 3 | PS51285 | |
| Domain | S_TK_X | 6.41e-03 | 56 | 126 | 3 | SM00133 | |
| Domain | ADAM_CR | 6.44e-03 | 18 | 126 | 2 | PF08516 | |
| Domain | RasGAP_dom | 6.44e-03 | 18 | 126 | 2 | IPR001936 | |
| Pathway | KEGG_PYRUVATE_METABOLISM | 1.17e-05 | 40 | 106 | 5 | M7934 | |
| Pathway | WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS | 4.53e-05 | 86 | 106 | 6 | M39375 | |
| Pathway | KEGG_PROPANOATE_METABOLISM | 1.04e-04 | 33 | 106 | 4 | M4086 | |
| Pubmed | CDC42BPG FRAS1 RPN2 RPS6KA1 MPDZ ANKRD50 CEMIP IBTK LLGL2 DROSHA AP1M1 AKAP13 EIF2AK4 SLC12A7 EPB41L1 PLCE1 | 3.92e-09 | 650 | 132 | 16 | 38777146 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ESPN PITPNM2 CDC42BPG SLC25A42 HIVEP2 ACACA NPEPPS OBSCN SYT2 PCGF3 SELENON REEP3 PTK6 AFMID PHKB AKAP13 EIF2AK4 ADI1 PNPLA7 TSEN15 EPB41L1 | 2.10e-07 | 1489 | 132 | 21 | 28611215 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.12e-06 | 202 | 132 | 8 | 33005030 | |
| Pubmed | 1.85e-06 | 7 | 132 | 3 | 14623241 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | DSTN ACACA RPN2 NPEPPS PSMA2 RPS15 AP1M2 LDHA PARP1 LLGL2 AHNAK DLD AKAP13 NME1 | 2.57e-06 | 807 | 132 | 14 | 30575818 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PITPNM2 ABCC3 FRAS1 HIVEP2 PLOD3 ARSJ ACACA OBSCN GEMIN5 ITPR2 C2CD3 LLGL2 CLCN7 MTOR AHNAK AKAP13 | 4.84e-06 | 1105 | 132 | 16 | 35748872 |
| Pubmed | PLOD3 RPN2 RPS15 DUSP22 ITPR2 PHKB PARP1 C2CD3 PTPN14 CLCN7 AHNAK CGN EIF2AK4 SLC12A7 EPB41L1 | 1.13e-05 | 1049 | 132 | 15 | 27880917 | |
| Pubmed | 1.15e-05 | 12 | 132 | 3 | 36154712 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 16144866 | ||
| Pubmed | Expression of hepatocyte growth factor and its receptor c-Met in human pituitary adenomas. | 1.43e-05 | 2 | 132 | 2 | 20200025 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 15192042 | ||
| Pubmed | Hepatocyte growth factor; expression, concentration and biological activity in chronic leg ulcers. | 1.43e-05 | 2 | 132 | 2 | 15659325 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 19318497 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 27893712 | ||
| Pubmed | Does hepatocyte growth factor/c-Met signal play synergetic role in lung cancer? | 1.43e-05 | 2 | 132 | 2 | 20178463 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 8631159 | ||
| Pubmed | Involvement of hepatocyte growth factor in branching morphogenesis of murine salivary gland. | 1.43e-05 | 2 | 132 | 2 | 14517989 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 25504327 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 32126881 | ||
| Pubmed | Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer. | 1.43e-05 | 2 | 132 | 2 | 27055253 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 21922134 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 12883672 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 25228590 | ||
| Pubmed | Hepatocyte growth factor enhances death receptor-induced apoptosis by up-regulating DR5. | 1.43e-05 | 2 | 132 | 2 | 18992144 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 24810547 | ||
| Pubmed | Autocrine and/or paracrine growth of aggressive ATLL cells caused by HGF and c-Met. | 1.43e-05 | 2 | 132 | 2 | 18813782 | |
| Pubmed | Over-expression of AQP7 contributes to improve insulin resistance in adipocytes. | 1.43e-05 | 2 | 132 | 2 | 22877989 | |
| Pubmed | Complete genomic structure of the CLCN6 and CLCN7 putative chloride channel genes(1). | 1.43e-05 | 2 | 132 | 2 | 10500249 | |
| Pubmed | State of the structure address on MET receptor activation by HGF. | 1.43e-05 | 2 | 132 | 2 | 33860789 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 26001768 | ||
| Pubmed | CAPRI regulates Ca(2+)-dependent inactivation of the Ras-MAPK pathway. | 1.43e-05 | 2 | 132 | 2 | 11448776 | |
| Pubmed | Involvement of hepatocyte growth factor in kidney development. | 1.43e-05 | 2 | 132 | 2 | 8200486 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 12233882 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 30309648 | ||
| Pubmed | Distinct intracellular signaling mediates C-MET regulation of dendritic growth and synaptogenesis. | 1.43e-05 | 2 | 132 | 2 | 26818605 | |
| Pubmed | Structural basis for agonism and antagonism of hepatocyte growth factor. | 1.43e-05 | 2 | 132 | 2 | 20624990 | |
| Pubmed | PARP-1 modulation of mTOR signaling in response to a DNA alkylating agent. | 1.43e-05 | 2 | 132 | 2 | 23110147 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 30590713 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 23123275 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 14759494 | ||
| Pubmed | Multiple roles for hepatocyte growth factor in sympathetic neuron development. | 1.43e-05 | 2 | 132 | 2 | 9620689 | |
| Pubmed | Allosteric peptide activators of pro-hepatocyte growth factor stimulate Met signaling. | 1.43e-05 | 2 | 132 | 2 | 20937841 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 10727259 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 23882082 | ||
| Pubmed | Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. | 1.43e-05 | 2 | 132 | 2 | 1655405 | |
| Pubmed | Dual Inhibition of Hedgehog and c-Met Pathways for Pancreatic Cancer Treatment. | 1.43e-05 | 2 | 132 | 2 | 28864680 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 8982163 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 20019837 | ||
| Pubmed | mTOR may interact with PARP-1 to regulate visible light-induced parthanatos in photoreceptors. | 1.43e-05 | 2 | 132 | 2 | 32066462 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 22850551 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 37482682 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 37879294 | ||
| Pubmed | A mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonist. | 1.43e-05 | 2 | 132 | 2 | 17804794 | |
| Pubmed | Absence of ALK and MET alterations in head and neck sarcomatoid carcinoma. | 1.43e-05 | 2 | 132 | 2 | 27262592 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 27455244 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 21968069 | ||
| Pubmed | Antitumor effect of dimethyl itaconate on thymic carcinoma by targeting LDHA-mTOR axis. | 1.43e-05 | 2 | 132 | 2 | 34293399 | |
| Pubmed | Differential Immune Checkpoint Protein Expression in HNSCC: The Role of HGF/MET Signaling. | 1.43e-05 | 2 | 132 | 2 | 39000441 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 24722154 | ||
| Pubmed | Crystal structure of the HGF beta-chain in complex with the Sema domain of the Met receptor. | 1.43e-05 | 2 | 132 | 2 | 15167892 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 25844809 | ||
| Pubmed | The impact of c-met/scatter factor receptor on dendritic cell migration. | 1.43e-05 | 2 | 132 | 2 | 12115601 | |
| Pubmed | Tumor Specific Recruitment and Reprogramming of Mesenchymal Stem Cells in Tumorigenesis. | 1.43e-05 | 2 | 132 | 2 | 26676563 | |
| Pubmed | Epigenetic upregulation of HGF and c-Met drives metastasis in hepatocellular carcinoma. | 1.43e-05 | 2 | 132 | 2 | 23723997 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 37432580 | ||
| Pubmed | Hepatocyte growth factor and c-Met expression in rat and human liver fibrosis. | 1.43e-05 | 2 | 132 | 2 | 15287857 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 25521737 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 28364348 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 12847110 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 17576812 | ||
| Pubmed | Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria. | 1.43e-05 | 2 | 132 | 2 | 20375988 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 7822413 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 8810314 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 22495710 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 8380735 | ||
| Pubmed | Hepatocyte Growth Factor: A Microenvironmental Resource for Leukemic Cell Growth. | 1.43e-05 | 2 | 132 | 2 | 30642077 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 23216249 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 25592281 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 25051373 | ||
| Pubmed | HGF/c-Met axis drives cancer aggressiveness in the neo-adjuvant setting of ovarian cancer. | 1.43e-05 | 2 | 132 | 2 | 24952592 | |
| Pubmed | Structural basis of hepatocyte growth factor/scatter factor and MET signalling. | 1.43e-05 | 2 | 132 | 2 | 16537482 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 18973760 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 23532910 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 30138330 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 30477470 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 22996389 | ||
| Pubmed | The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myeloma. | 1.43e-05 | 2 | 132 | 2 | 12682635 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 31221203 | ||
| Pubmed | Identifying mechanisms for therapeutic intervention in chordoma: c-Met oncoprotein. | 1.43e-05 | 2 | 132 | 2 | 19050584 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 20661229 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 20580899 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 28559461 | ||
| Pubmed | Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle. | 1.43e-05 | 2 | 132 | 2 | 18334579 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 21130427 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 17372204 | ||
| Pubmed | Mu1B, a novel adaptor medium chain expressed in polarized epithelial cells. | 1.43e-05 | 2 | 132 | 2 | 10338135 | |
| Pubmed | Hepatocyte growth factor/c-Met signaling is required for β-cell regeneration. | 1.43e-05 | 2 | 132 | 2 | 24089510 | |
| Pubmed | NK4 gene therapy inhibits HGF/Met-induced growth of human cholangiocarcinoma cells. | 1.43e-05 | 2 | 132 | 2 | 23314853 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 26822708 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 32788873 | ||
| Interaction | LRRC31 interactions | 7.45e-06 | 205 | 130 | 9 | int:LRRC31 | |
| GeneFamily | Chloride voltage-gated channels | 9.59e-04 | 10 | 85 | 2 | 302 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 9.59e-04 | 10 | 85 | 2 | 830 | |
| GeneFamily | CD molecules|Type II classical cadherins | 1.65e-03 | 13 | 85 | 2 | 1186 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D | GBP6 ACACA DUSP22 AFMID MET IBTK C2CD3 MTOR AHNAK CLN5 DLD EIF2AK4 PNPLA7 EPB41L1 | 4.58e-06 | 646 | 131 | 14 | M2419 |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D | GBP6 ACACA DUSP22 AFMID MET IBTK C2CD3 MTOR AHNAK CLN5 DLD EIF2AK4 PNPLA7 EPB41L1 | 7.55e-06 | 675 | 131 | 14 | MM1073 |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.50e-07 | 157 | 132 | 7 | 6ee2692f705bdd93ba523dffaf2f0cd921b47e28 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-07 | 159 | 132 | 7 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-07 | 159 | 132 | 7 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-06 | 184 | 132 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-06 | 184 | 132 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-06 | 184 | 132 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.41e-06 | 186 | 132 | 7 | 8915436d09775f2828a7678af203b1082b36e21c | |
| ToppCell | droplet-Marrow-nan-21m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 188 | 132 | 7 | f94dc08948a823f47882aa0714b9a60de4ff85d5 | |
| ToppCell | droplet-Marrow-nan-21m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 188 | 132 | 7 | 7c67330c36696a7772364af67c6df4e6406fa742 | |
| ToppCell | IPF-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 1.74e-06 | 192 | 132 | 7 | 356e7a820b744a0ac87352a8d0e6e8d9fa9ed7d2 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-06 | 193 | 132 | 7 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-06 | 193 | 132 | 7 | 263d185af6ed80e639f864e4966268e0862c61dc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-06 | 193 | 132 | 7 | 80e058c224749b5fe0ba3e944b48317c2371cb63 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-06 | 193 | 132 | 7 | b991fbbb4618401624f0b3045f0e81a606d3a763 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-06 | 193 | 132 | 7 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-06 | 195 | 132 | 7 | 938b31dbf1674ee6fd0123bc88391ddcaf151217 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-06 | 195 | 132 | 7 | d39e9e6544f49e677ebe528c6fe60b99a3630e30 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / Treatment groups by lineage, cell group, cell type | 2.13e-06 | 198 | 132 | 7 | d087e738d69ca9853553fde46d4e7a8906439d32 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.13e-06 | 198 | 132 | 7 | d499dced27b0c0e21acfda2c20fa5c114f605085 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.28e-06 | 200 | 132 | 7 | 51265e30f1138fd79733001d0db759f3dab0aaeb | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.75e-06 | 158 | 132 | 6 | 7f5426585d0d299d2b48e5fcb349950feffdef33 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.75e-06 | 158 | 132 | 6 | d78e7e52657dc094430291fec07e9c298be9e584 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.03e-05 | 166 | 132 | 6 | 6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.10e-05 | 168 | 132 | 6 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination__)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-05 | 171 | 132 | 6 | d1e87478d8c0329e662849823f5c7604f20e1b1a | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.26e-05 | 172 | 132 | 6 | 9a256db817c1af1802203cc88a55d608fb328c63 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.26e-05 | 172 | 132 | 6 | 92e76cbf4807704790f42cf2507e92f85cd3bc92 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.30e-05 | 173 | 132 | 6 | ee7d1429f23f1b89a9a9f7bc07a84a44cf7acd1c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.30e-05 | 173 | 132 | 6 | ee972d9cc68755926512fd3bbe1267098c67cd94 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.30e-05 | 173 | 132 | 6 | 3725525b99a6011eda2ff5459b4fd2e1eab1f090 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-05 | 174 | 132 | 6 | 2947e5906b172d149412fa4e77476fce4ea695d2 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.58e-05 | 179 | 132 | 6 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-05 | 183 | 132 | 6 | 85446581999cd66b171c4f69b7eb8b0bbbaa8617 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.84e-05 | 184 | 132 | 6 | 9cc5c588f7c6631b3fb8a522214a09ca32947e72 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.84e-05 | 184 | 132 | 6 | 607b55022de21ddb6a2d75e085df76df7abf6624 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.90e-05 | 185 | 132 | 6 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.90e-05 | 185 | 132 | 6 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Parm1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.01e-05 | 111 | 132 | 5 | 1847dde68d349114286bc3317be6339666df4aa2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 187 | 132 | 6 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 2.02e-05 | 187 | 132 | 6 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.08e-05 | 188 | 132 | 6 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-05 | 188 | 132 | 6 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | 368C-Epithelial_cells-Epithelial-I_(AT1)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.08e-05 | 188 | 132 | 6 | c74771584b3ba9561a99a54bf55a9203ddf8eff8 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-I_(AT1)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.08e-05 | 188 | 132 | 6 | 9155b9a92496e75646778c025b02947e9e9ec73a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-05 | 188 | 132 | 6 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.14e-05 | 189 | 132 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-05 | 189 | 132 | 6 | aadb7a2de4cbe7f0958651f2739bba430b93f5c1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-05 | 189 | 132 | 6 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-05 | 189 | 132 | 6 | 8977f3295b7df7c7474b3f371de90a82ae4bb50c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 2.14e-05 | 189 | 132 | 6 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-05 | 190 | 132 | 6 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 190 | 132 | 6 | e2fdbfaf08da3274b6bdda615386aa880040a90a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.21e-05 | 190 | 132 | 6 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.27e-05 | 191 | 132 | 6 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-05 | 191 | 132 | 6 | 5a67ff17fb4b9eff641176dff07830c9cd73754e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-05 | 191 | 132 | 6 | 55ab2854a02cdcfc395e49870ccb7290b5e5471d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 192 | 132 | 6 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_BHLHE22|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.34e-05 | 192 | 132 | 6 | 25460ca9ebd3d49f666394cf99ab77a5e8f77250 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-05 | 194 | 132 | 6 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | RA|World / Chamber and Cluster_Paper | 2.48e-05 | 194 | 132 | 6 | 08f0afbb68a63150fbe107a5337299081c3f69e4 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.55e-05 | 195 | 132 | 6 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.63e-05 | 196 | 132 | 6 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.70e-05 | 197 | 132 | 6 | ad6f047d003c08413264f39a30ba0f7639a257cd | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-05 | 197 | 132 | 6 | 8f009a15f154b3bb184b489da4722b7c27de7e11 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.78e-05 | 198 | 132 | 6 | d12f37527399038a8f030b45b176bda5c7c8a7ad | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 2.78e-05 | 198 | 132 | 6 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / Treatment groups by lineage, cell group, cell type | 2.78e-05 | 198 | 132 | 6 | 655df75b9692d815c7f6910275e1f684ac63bf62 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.86e-05 | 199 | 132 | 6 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 2.86e-05 | 199 | 132 | 6 | 0447f8f53389fe7c6ddc04a97d86e74122ea16f4 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-FOLH1B--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.94e-05 | 200 | 132 | 6 | bdda59ffa0496256dd7a5937e88baac5c2a656c3 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-FOLH1B|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.94e-05 | 200 | 132 | 6 | dff0be30309b6f5f8757b0378ef05ce97f75dbe8 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-FOLH1B---L4-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.94e-05 | 200 | 132 | 6 | c3474e8a03ec4869fd3636a5559d36dd9c5fd414 | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 2.94e-05 | 200 | 132 | 6 | e3c15e0e1c2602b0cc9ab8cc50c978d265350c94 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Duct|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.94e-05 | 200 | 132 | 6 | 1b527bebbca1ef8c52449e40beb9358e37494e04 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.94e-05 | 200 | 132 | 6 | 9da214f756a03516eaafde00289b90f69623b9f3 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-FOLH1B-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.94e-05 | 200 | 132 | 6 | 5c0c09e7b84fed053b299848bdff63ab842a445c | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Reln_(Neuron.Gad1Gad2.Cplx3-Reln)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.24e-05 | 61 | 132 | 4 | 06aab3f1743ced1e46d22f0310f1cdb70c7a108e | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Reln_(Neuron.Gad1Gad2.Cplx3-Reln)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.24e-05 | 61 | 132 | 4 | fec6c9a4e12c260338856567bf547f914f473dbb | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Hs3st6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.30e-05 | 123 | 132 | 5 | 64a2d7e40d9c948a9ccaf61c465fb2207e0b7ab8 | |
| ToppCell | TCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma-4|TCGA-Uterus / Sample_Type by Project: Shred V9 | 4.46e-05 | 131 | 132 | 5 | 1801611e6b63aa07629e7ccc692f45a7e93c8dd8 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.76e-05 | 143 | 132 | 5 | b4ed3855652fdf32f97cb7c18cab4f4f4c24d5c7 | |
| ToppCell | Control-APC-like-Transitioning_MDM|Control / group, cell type (main and fine annotations) | 6.76e-05 | 143 | 132 | 5 | ffc1f497245d559e97e40d1bc4ee14e1ef09040c | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.99e-05 | 144 | 132 | 5 | e9d62f202f0fa8747961036ef0eafed91fe8a42f | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col18a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.96e-05 | 148 | 132 | 5 | fc80c02b51cf55a04ce550838ee2f41d8f656f41 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.21e-05 | 149 | 132 | 5 | a85a051e0d82430160967e72fa04b55f43e84513 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.48e-05 | 150 | 132 | 5 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.48e-05 | 150 | 132 | 5 | 7a381f5ae94eba5eb60dcbf83416b4eb18c279ea | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Nfib_(Amygdala)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.04e-04 | 82 | 132 | 4 | ab081620b6113f843fede23da0a18720111ffc7c | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Nfib_(Amygdala)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.04e-04 | 82 | 132 | 4 | 1ca848a18463b1344e23e3ad1b5d01ae27c00586 | |
| ToppCell | COVID-19_Severe-PLT_3|COVID-19_Severe / Disease Group and Platelet Clusters | 1.18e-04 | 161 | 132 | 5 | cd4ed3fa3cd8b159ab10cf9b2ad5cd05640530d0 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 165 | 132 | 5 | d449a568664a81d9b5538e8f409301448a32ac37 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 165 | 132 | 5 | e24621c8d4dbafb407033d832fe9337f13feae34 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-04 | 166 | 132 | 5 | bcdaab49bde5beba750b76fdcc3781a3c12c4fff | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-04 | 166 | 132 | 5 | 5e3b998d740b24f790fad37350d704ca0ea10b77 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 167 | 132 | 5 | 1248f809afbcccb42ce9e29cfe6fa1f6f6b65005 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.40e-04 | 167 | 132 | 5 | 784776d1fcc098f84d3c2eca58fa56cb9428f434 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 167 | 132 | 5 | a66552667aa6e8992c159df27a57c2e8ae14a9ce | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 167 | 132 | 5 | a35ace2c722936d2a3e1f0826e5b6ec6b1340d2b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 169 | 132 | 5 | 0332f539a2f7d6dcd081a5d2f567290721f5a329 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 1.52e-04 | 170 | 132 | 5 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| Drug | aldonates | 8.48e-07 | 90 | 130 | 7 | CID000000752 | |
| Drug | hydroxypyruvate | 6.38e-06 | 46 | 130 | 5 | CID000000964 | |
| Drug | aspartate | AMPD1 PLOD3 SHMT1 CASP5 LDHA LDHC PARP1 CLCN6 CLCN7 AGXT DLD SLC12A7 ALPI | 8.73e-06 | 518 | 130 | 13 | CID000000424 |
| Drug | N-dodecyl morpholine | 9.98e-06 | 8 | 130 | 3 | CID000073764 | |
| Drug | alpha-hydroxybutyrate | 1.70e-05 | 56 | 130 | 5 | CID000011266 | |
| Drug | bis-NAD | 2.12e-05 | 10 | 130 | 3 | CID003081557 | |
| Drug | phosphoenolthiopyruvate | 2.12e-05 | 10 | 130 | 3 | CID000194910 | |
| Drug | N,N'-diphenyl-p-phenylenediamine | 2.48e-05 | 30 | 130 | 4 | CID000006319 | |
| Drug | hexandiol | 2.90e-05 | 11 | 130 | 3 | CID000147023 | |
| Drug | polyvinylpyridine-N-oxide | 2.90e-05 | 11 | 130 | 3 | CID000024772 | |
| Drug | bis(sulfosuccinimidyl)suberate | 3.24e-05 | 2 | 130 | 2 | ctd:C035760 | |
| Drug | ((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide) | 3.24e-05 | 2 | 130 | 2 | ctd:C478479 | |
| Drug | LG61 | 3.85e-05 | 12 | 130 | 3 | CID000520177 | |
| Drug | AC1L6XQE | 4.71e-05 | 69 | 130 | 5 | CID000301119 | |
| Drug | glycogen | 4.87e-05 | 443 | 130 | 11 | CID000439177 | |
| Drug | 3-phosphoglycerate | 4.97e-05 | 114 | 130 | 6 | CID000000724 | |
| Drug | 2-oxohexanoate | 4.99e-05 | 13 | 130 | 3 | CID000159664 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 2.08e-05 | 128 | 128 | 6 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 2.08e-05 | 128 | 128 | 6 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 2.08e-05 | 128 | 128 | 6 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 2.08e-05 | 128 | 128 | 6 | C1306837 | |
| Disease | Renal Cell Carcinoma | 2.08e-05 | 128 | 128 | 6 | C0007134 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 4.72e-05 | 148 | 128 | 6 | C0279702 | |
| Disease | Neuroblastoma | 5.21e-05 | 47 | 128 | 4 | C0027819 | |
| Disease | disease of metabolism (implicated_via_orthology) | 1.00e-04 | 21 | 128 | 3 | DOID:0014667 (implicated_via_orthology) | |
| Disease | neuroblastoma (implicated_via_orthology) | 1.85e-04 | 5 | 128 | 2 | DOID:769 (implicated_via_orthology) | |
| Disease | squamous cell carcinoma | 2.10e-04 | 67 | 128 | 4 | EFO_0000707 | |
| Disease | dentures | 2.48e-04 | 70 | 128 | 4 | EFO_0010078 | |
| Disease | dental caries, dentures | 2.48e-04 | 70 | 128 | 4 | EFO_0003819, EFO_0010078 | |
| Disease | Nonsyndromic Deafness | 4.34e-04 | 81 | 128 | 4 | C3711374 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 5.14e-04 | 8 | 128 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 7.41e-04 | 163 | 128 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 7.65e-04 | 447 | 128 | 8 | C3714756 | |
| Disease | erectile dysfunction | 8.09e-04 | 42 | 128 | 3 | EFO_0004234 | |
| Disease | Colorectal Carcinoma | 9.98e-04 | 702 | 128 | 10 | C0009402 | |
| Disease | maleate measurement | 1.00e-03 | 11 | 128 | 2 | EFO_0010509 | |
| Disease | Copper-Overload Cirrhosis | 1.00e-03 | 11 | 128 | 2 | C1876165 | |
| Disease | Congenital myopathy (disorder) | 1.20e-03 | 12 | 128 | 2 | C0270960 | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 1.41e-03 | 13 | 128 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | serum alanine aminotransferase measurement | BTBD8 STAG1 SHMT1 XYLT1 MET ALDH1A2 CDH20 CLCN6 EPHA2 AHNAK PLCE1 | 1.45e-03 | 869 | 128 | 11 | EFO_0004735 |
| Disease | lysophosphatidylcholine 15:0 measurement | 1.64e-03 | 14 | 128 | 2 | EFO_0020941 | |
| Disease | hepcidin:ferritin ratio | 1.77e-03 | 55 | 128 | 3 | EFO_0007901 | |
| Disease | 1,3,7-trimethylurate measurement | 1.89e-03 | 15 | 128 | 2 | EFO_0021172 | |
| Disease | idiopathic pulmonary fibrosis | 1.97e-03 | 57 | 128 | 3 | EFO_0000768 | |
| Disease | Hypertrophic Cardiomyopathy | 1.97e-03 | 57 | 128 | 3 | C0007194 | |
| Disease | Glycogen storage disease | 2.43e-03 | 17 | 128 | 2 | cv:C0017919 | |
| Disease | Malignant neoplasm of breast | CATSPERE OBSCN SHMT1 GIMAP1 PHKB PARP1 PTPN14 LLGL2 CDH20 MTOR AP1M1 ALK | 2.52e-03 | 1074 | 128 | 12 | C0006142 |
| Disease | mean reticulocyte volume | NPEPPS RPS6KA1 AP1M2 NEB BLVRB CLCN6 MTOR AKAP13 SLC12A7 ACOXL | 2.58e-03 | 799 | 128 | 10 | EFO_0010701 |
| Disease | Neoplasm Metastasis | 2.61e-03 | 217 | 128 | 5 | C0027627 | |
| Disease | migraine disorder, systolic blood pressure | 2.73e-03 | 18 | 128 | 2 | EFO_0006335, MONDO_0005277 | |
| Disease | neutrophil count | BNC2 HIVEP2 SLC6A17 PCGF3 ITPR2 MET PTPN14 CGN UGCG AKAP13 SLC12A7 MAP2K5 TNXB ACOXL | 2.74e-03 | 1382 | 128 | 14 | EFO_0004833 |
| Disease | skin pigmentation measurement | 3.04e-03 | 137 | 128 | 4 | EFO_0007009 | |
| Disease | squamous cell carcinoma (is_marker_for) | 3.04e-03 | 19 | 128 | 2 | DOID:1749 (is_marker_for) | |
| Disease | ovarian cancer (is_marker_for) | 3.25e-03 | 68 | 128 | 3 | DOID:2394 (is_marker_for) | |
| Disease | Deaf Mutism | 3.37e-03 | 20 | 128 | 2 | C4082305 | |
| Disease | Deafness, Acquired | 3.37e-03 | 20 | 128 | 2 | C0751068 | |
| Disease | Hearing Loss, Extreme | 3.37e-03 | 20 | 128 | 2 | C0086395 | |
| Disease | Complete Hearing Loss | 3.37e-03 | 20 | 128 | 2 | C0581883 | |
| Disease | Bilateral Deafness | 3.37e-03 | 20 | 128 | 2 | C3665473 | |
| Disease | end stage renal disease (implicated_via_orthology) | 3.37e-03 | 20 | 128 | 2 | DOID:783 (implicated_via_orthology) | |
| Disease | Prelingual Deafness | 3.37e-03 | 20 | 128 | 2 | C0011052 | |
| Disease | Cardiomyopathies, Primary | 3.39e-03 | 69 | 128 | 3 | C0033141 | |
| Disease | Myocardial Diseases, Secondary | 3.39e-03 | 69 | 128 | 3 | C0036529 | |
| Disease | kidney disease (biomarker_via_orthology) | 3.71e-03 | 21 | 128 | 2 | DOID:557 (biomarker_via_orthology) | |
| Disease | migraine disorder, endometriosis | 3.97e-03 | 73 | 128 | 3 | EFO_0001065, MONDO_0005277 | |
| Disease | Hepatitis, Chronic | 4.07e-03 | 22 | 128 | 2 | C0019189 | |
| Disease | Chronic active hepatitis | 4.07e-03 | 22 | 128 | 2 | C0520463 | |
| Disease | Chronic Persistent Hepatitis | 4.07e-03 | 22 | 128 | 2 | C0149519 | |
| Disease | Cryptogenic Chronic Hepatitis | 4.07e-03 | 22 | 128 | 2 | C0524611 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NSGKLLDHVLIEMGY | 431 | Q9BXT4 | |
| LDHVLIEMGYGLKPS | 436 | Q9BXT4 | |
| YHLGMKGPDIGEVKD | 586 | Q9UKF5 | |
| TLLHVPIDVYLAMGG | 106 | H3BQW9 | |
| YIMLGKIHLLEGDLD | 171 | Q96RK4 | |
| HAGGDPMCKILIGLY | 96 | O00421 | |
| GMCIYLDPKEAEHLG | 796 | A0A096LP49 | |
| GKEYLMRAHFGLPSV | 351 | Q9Y6Q5 | |
| GHSGMYVFRVKILDP | 866 | Q5SY80 | |
| EILDGLAYIHEKGMI | 831 | Q9P2K8 | |
| FLVKIYGAQHPMGLD | 916 | Q6ZN30 | |
| KIHGMTIPVDGDYFT | 156 | O94788 | |
| YHLGMAIPDIGEVKD | 596 | O43506 | |
| LEPYTLLAAGIGEAM | 601 | Q12802 | |
| ESGLKYVAVMPPHIG | 141 | P30043 | |
| GKEYLMRAHFGLPSV | 351 | Q9BXS5 | |
| LYGVEQKGKHLSMVP | 106 | Q8WTQ4 | |
| MHLYLGAAKVEVGTE | 1401 | Q13085 | |
| HLKGPNVKGEYDVTM | 826 | Q09666 | |
| PENLGYHLKMKDGVV | 201 | P23109 | |
| KDGMTPLLVAAYEGH | 746 | Q9ULJ7 | |
| GVTITDPFKHFVGML | 61 | P60981 | |
| KMIDLGLLLHPGAYF | 1201 | Q00975 | |
| GKPMYLHIGEEIDGV | 471 | Q8WUJ3 | |
| AMRLGAEVYHTLKGV | 181 | P09104 | |
| GGELGVHMYLLIFLK | 281 | Q9NT62 | |
| PGVTAIDMMYKEGLH | 171 | Q9NUZ1 | |
| LKVAGMQYLHGVLGP | 356 | O43374 | |
| FYHKLGMEVPGDIKG | 96 | Q3KNV8 | |
| LKVAGMQYLHGVLGP | 356 | C9J798 | |
| YGIAPKGTLDHMVDQ | 126 | Q63HM1 | |
| LGEVALGNMYELKHA | 921 | P09874 | |
| AGEKIMYTLVSVPHG | 346 | Q14571 | |
| LEGKVHMKGSVAYVP | 681 | O15438 | |
| EILQAMEEGKGHYGP | 241 | Q6DT37 | |
| HPVSTMIKGLYGIKD | 271 | P00338 | |
| AGGYENVPTVDIHMK | 601 | O60568 | |
| DGIQMPYGDILLHTG | 71 | Q15777 | |
| PGIGYMIQDTEDHKV | 396 | Q6TGC4 | |
| ELHKTYRGMTPGEAE | 256 | Q9H4G0 | |
| YGVLLHELGLDEPLM | 176 | Q6N063 | |
| LTDGLHVDTGRMKIY | 2056 | Q86XX4 | |
| LMYSVHEGIRGIPLE | 1881 | Q9NZR2 | |
| TMVLDLCHKPGGREY | 1126 | Q8IV33 | |
| IKLYGAPGVEFMGLH | 56 | Q6P1M3 | |
| KVLVSGGHMEYKVDP | 381 | Q9P2D0 | |
| DIFGEMVHLYAKPGK | 806 | Q9NS40 | |
| PQKLKEVGYSTHMVG | 161 | Q5FYB0 | |
| VAYEDHGITVLPKMG | 291 | A6NL99 | |
| VAYEDHGITVLPKMG | 296 | A0A075B734 | |
| DMGALPIHYAAAKGD | 136 | B1AK53 | |
| MKHLGLPTTGYEDVA | 1131 | Q5JUK3 | |
| KIVGDVFIEGLYDMH | 591 | P51798 | |
| GGSLDVYRKMPEHVL | 246 | Q13163 | |
| HPVSTMVKGLYGIKE | 271 | P07864 | |
| FSVPGGHKLYMETKE | 426 | Q6ZN66 | |
| VAYEDHGITVLPKMG | 291 | O14520 | |
| VYGPEGSDLVLMKLA | 571 | P14210 | |
| GASVIRMLHDYIGDK | 441 | A6NEC2 | |
| PESHRLGVGVYPIKM | 1071 | Q9BZ72 | |
| HENKGVYVLMSGLDL | 271 | P26440 | |
| CDPKDGHLLMDGGYI | 1071 | Q6ZV29 | |
| SHKPDEIYGMIERLS | 511 | Q86U44 | |
| MVSRDQAHLGPKYVG | 1 | Q13882 | |
| GVELHAGPKYEMRSQ | 4106 | Q5VST9 | |
| VTHLMGLFEPGDTKY | 281 | P09923 | |
| ADMLLHGIKVVSYGD | 276 | Q9NWS6 | |
| VAGGLFVEKEGPMIH | 191 | P51797 | |
| GMVEGLVLEHKGAHY | 206 | Q8WWP7 | |
| GPGYEGRHIAMEKVA | 371 | Q969P0 | |
| LPARNGAHYDIVGMK | 206 | P51878 | |
| HVLLMVPDGKDFISG | 806 | Q4AC94 | |
| DPLYVGKLHSDMDRG | 76 | Q9HBT6 | |
| APHYLTAVGMGAKVE | 331 | P29317 | |
| MHFIYGGTLDIPDKT | 261 | Q5XKL5 | |
| MTEKVGLVHGLPYVA | 161 | Q16739 | |
| YAIGDVVAGPMLAHK | 351 | P09622 | |
| SVHDSARPMLEGVKY | 36 | Q9NRW4 | |
| GLVEEMHAAYGKPVF | 186 | P04180 | |
| MAYVALSDKPHLSGE | 1 | Q8NAJ2 | |
| MGSDPLYVGKLHSDV | 61 | Q9ULB5 | |
| TALKDRHTGPVYAEM | 1331 | Q49AJ0 | |
| HLHELGIVYRDMKPE | 306 | Q8WTQ7 | |
| TIGFAIYEVPKEMHG | 501 | P20807 | |
| IVGSVLEGTYLDKHM | 726 | Q9Y666 | |
| GASVIRMLHDYIGDK | 441 | P55786 | |
| HAMEYELQIRGGDKP | 881 | Q93100 | |
| LGALDPYKHKVNIGM | 891 | P42345 | |
| GVLEYAMKHFGELEI | 1431 | P42345 | |
| IHTYPKGVGLLARAM | 976 | Q6ZUA9 | |
| QALKPMYHRVVSGLG | 201 | Q12947 | |
| AVYTALVEPHGRIMG | 126 | P34896 | |
| GSPLVVLPYMKHGDL | 1151 | P08581 | |
| DVGGLSDPYVKIHLM | 301 | Q8N9I0 | |
| DGGKEVLSMHQILLY | 691 | Q9NRR4 | |
| MSIQVEHPAGGYKKL | 1 | Q16518 | |
| MTKDPGGHYTLQEVE | 126 | P21549 | |
| PIKADVLFIHGLMGA | 391 | Q96JX3 | |
| FAGLVKYMHSGPVVA | 61 | P15531 | |
| LDLFAVKAVYMGHPG | 936 | Q9P212 | |
| KAHSGILPAEAELMY | 191 | Q15678 | |
| LEEMKRLVSEIYGGH | 166 | Q13516 | |
| VATHAGLYRKPVTGM | 251 | Q96T60 | |
| EGLKTLYHGFMPTVL | 181 | Q86VD7 | |
| EGPYSDNEMLTHKGL | 206 | Q6NUK4 | |
| YTPALKVMEGHGEVN | 966 | Q9UM73 | |
| YGDLLGHLKIMHDAI | 106 | O75503 | |
| VDHMKATIYGILREG | 311 | Q9P2M7 | |
| GLMAHLLIHTGEKPY | 386 | Q8N9Z0 | |
| LHPEIGLLKYMNSGG | 706 | Q9BXU1 | |
| EIKPEMIGHYLGEFS | 106 | P62841 | |
| YLSGIDMIHGTPVLD | 141 | Q9BU70 | |
| GETYCRHKLGLLMPE | 281 | Q86Y38 | |
| LSYMVSLEVGEEKHP | 181 | Q01534 | |
| YGTLTGELHMIELEK | 1341 | O75970 | |
| PHLAYLRTGVKIGEM | 126 | Q9BWD1 | |
| VDADPHGIEIMCIYK | 276 | Q9Y5K1 | |
| YKLMDHVGTEPSIKE | 216 | P04844 | |
| LAGLHLEKYSFPVEM | 511 | Q9NZV5 | |
| GVTISGLEPDHKYKM | 2246 | P22105 | |
| GVTISGLEPDHKYKM | 2896 | P22105 | |
| TLYRMIDIEGKGHLE | 901 | Q8TEQ6 | |
| YDDVRIPAMAAHLKG | 606 | Q6UXI7 | |
| EPITKHIGLVYSGMG | 66 | P25787 | |
| CYRLLKTGIEHGAMP | 716 | Q8WVM7 | |
| RYMIDIFVHGDLKPG | 271 | Q13061 | |
| GAVDGILHMFTPKLD | 276 | Q9H1V8 | |
| IMEVAHGKDHPYISE | 411 | Q9NRG4 | |
| YHGSLEESLGGPMKV | 311 | P31629 | |
| GTHPKYLEMMELDIG | 41 | Q8WW01 | |
| KGDMVTLPAGIYHRF | 121 | Q9BV57 | |
| DGKHVYLVTELMRGG | 481 | Q15418 | |
| SLTLHGNPMEEEKGY | 131 | Q96E66 | |
| VVATPVMTYGHLEGL | 66 | Q9H1M0 | |
| EGPKYKMHIDRNTGI | 1286 | P52179 | |
| KQKGHYVGVPTMRDD | 4256 | P20929 |